Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123789243 | 12378924 | 3 | F | 20151203 | 20160715 | 20160517 | 20160727 | EXP | GB-JNJFOC-20160420790 | JANSSEN | 50.96 | YR | A | F | Y | 0.00000 | 20160727 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123789243 | 12378924 | 1 | SS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | FES09NB | 0 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 123789243 | 12378924 | 2 | PS | STELARA | USTEKINUMAB | 1 | Subcutaneous | U | FES09NB | 125261 | 45 | MG | SOLUTION FOR INJECTION | ||||||
| 123789243 | 12378924 | 3 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 0 | 500 | MG | TABLETS | TID | |||||||
| 123789243 | 12378924 | 4 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | 40 | MG | TABLETS | QD | |||||||
| 123789243 | 12378924 | 5 | C | NAPROXEN. | NAPROXEN | 1 | Oral | WITH MEALS | 0 | 250 | MG | TABLETS | BID | ||||||
| 123789243 | 12378924 | 6 | C | SEBCO | 2 | Topical | 0 | OINTMENT | |||||||||||
| 123789243 | 12378924 | 7 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | ONE TABLET EVERY EVENING | 0 | 45 | MG | TABLETS | QD | ||||||
| 123789243 | 12378924 | 8 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 50MG AT NIGHT | 0 | 25 | MG | TABLETS | |||||||
| 123789243 | 12378924 | 9 | C | KETOCONAZOLE. | KETOCONAZOLE | 1 | Topical | 0 | 2 | PCT | SHAMPOO | BIW | |||||||
| 123789243 | 12378924 | 10 | C | CLOBETASONE BUTYRATE | CLOBETASONE BUTYRATE | 1 | Topical | TWICE DAILY FO 2-3 WEEKS THEN IN SHORT SHARP BURSTS AS NEEDED | 0 | CREAM | |||||||||
| 123789243 | 12378924 | 11 | C | OXYTETRACYCLINE | OXYTETRACYCLINE | 1 | Topical | TWICE DAILY FO 2-3 WEEKS THEN IN SHORT SHARP BURSTS AS NEEDED | 0 | OINTMENT | |||||||||
| 123789243 | 12378924 | 12 | C | NYSTATIN. | NYSTATIN | 1 | Topical | TWICE DAILY FO 2-3 WEEKS THEN IN SHORT SHARP BURSTS AS NEEDED | 0 | OINTMENT | |||||||||
| 123789243 | 12378924 | 13 | C | SALAMOL | ALBUTEROL | 1 | Respiratory (inhalation) | INHALE TWO PUFFS 4 TO 6 HOURLY WHEN REQUIRED | 0 | 100 | UG | INHALATION | |||||||
| 123789243 | 12378924 | 14 | C | HUMALOG | INSULIN LISPRO | 1 | Unknown | 100 UNITS/ML | 0 | 100 | DF | SOLUTION FOR INJECTION | |||||||
| 123789243 | 12378924 | 15 | C | HYDROXYZINE | HYDROXYZINEHYDROXYZINE HYDROCHLORIDE | 1 | Oral | 0 | 25 | MG | TABLETS | ||||||||
| 123789243 | 12378924 | 16 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | MODIFIED-RELEASE TABLET | Q12H | |||||||
| 123789243 | 12378924 | 17 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 0 | 30 | MG | CAPSULES | QD | |||||||
| 123789243 | 12378924 | 18 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | TWO TABS FOUR TIMES A DAY TO RELIEVE PAIN | 0 | 500 | MG | TABLETS | |||||||
| 123789243 | 12378924 | 19 | C | FOSTAIR | BECLOMETHASONEFORMOTEROL | 1 | Respiratory (inhalation) | 2 PUFFS TWICE A DAY | 0 | 100 | UG | INHALATION | BID | ||||||
| 123789243 | 12378924 | 20 | C | MOMETASONE | MOMETASONE | 1 | Topical | APPLY SPARINGLY ONCE A DAY TO PSORIATIC PATCHES | 0 | .1 | PCT | CREAM | QD | ||||||
| 123789243 | 12378924 | 21 | C | TIOTROPIUM BROMIDE | TIOTROPIUM BROMIDE | 1 | Respiratory (inhalation) | INHALE ONE CAPSULE DAILY AT THE SAME TIME EACH DAY | 0 | 18 | UG | POWDER | QD | ||||||
| 123789243 | 12378924 | 22 | C | INTAL | CROMOLYN SODIUM | 1 | Ophthalmic | ONE OR TWO DROPS TO EACH EYE FOUR TIMES A DAV | 0 | 2 | PCT | DROPS | QID | ||||||
| 123789243 | 12378924 | 23 | C | BECLOMETASONE | BECLOMETHASONE DIPROPIONATE | 1 | Nasal | SPRAY INTO EACH NOSTRIL TWICE A DAY | 0 | 50 | UG | SPRAY | BID | ||||||
| 123789243 | 12378924 | 24 | C | LOTRIDERM | BETAMETHASONE DIPROPIONATECLOTRIMAZOLE | 1 | Topical | EVERY DAY THINNLY FOR 10 DAYS IF REQUIRED | 0 | CREAM | |||||||||
| 123789243 | 12378924 | 25 | C | CALCIPOTRIOL | CALCIPOTRIENE | 1 | Topical | 0 | .005 | PCT | OINTMENT | ||||||||
| 123789243 | 12378924 | 26 | C | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | Topical | 0 | .05 | PCT | OINTMENT | ||||||||
| 123789243 | 12378924 | 27 | C | EUMOVATE | CLOBETASONE BUTYRATE | 1 | Topical | TO BE APPLIED SPARINGLY ONCE TO TWICE DAILY BEHIND YOUR EARS AND FORHEAD FOR UPTO FOUR WEEKS | 0 | .05 | PCT | OINTMENT | |||||||
| 123789243 | 12378924 | 28 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Topical | 0 | 500 | MG | CREAM | ||||||||
| 123789243 | 12378924 | 29 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Topical | 0 | 2 | PCT | CREAM | ||||||||
| 123789243 | 12378924 | 30 | C | GABAPENTIN. | GABAPENTIN | 1 | Oral | TAKE TWO TABLETS IN THE MORNING AND TWO IN THE AFTERNOON, TAKE THREE TABLETS AT NIGHT | 0 | 300 | MG | CAPSULES | |||||||
| 123789243 | 12378924 | 31 | C | MEBEVERINE | MEBEVERINE | 1 | Oral | BEFORE FOOD | 0 | 135 | MG | TABLETS | |||||||
| 123789243 | 12378924 | 32 | C | LOPERAMIDE | LOPERAMIDE | 1 | Oral | TWO CAPSULES IMMEDIATELY THEN ONE | 0 | 2 | MG | CAPSULES | |||||||
| 123789243 | 12378924 | 33 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 0 | 10 | MG | TABLETS | ||||||||
| 123789243 | 12378924 | 34 | C | CAPASAL | 2 | Topical | 0 | SHAMPOO | |||||||||||
| 123789243 | 12378924 | 35 | C | NITROFURANTOIN. | NITROFURANTOIN | 1 | Oral | 0 | 50 | MG | TABLETS | QID | |||||||
| 123789243 | 12378924 | 36 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 0 | 150 | MG | CAPSULES | ||||||||
| 123789243 | 12378924 | 37 | C | DIPROBASE | CHLOROCRESOL | 1 | Topical | 0 | OINTMENT | ||||||||||
| 123789243 | 12378924 | 38 | C | FUCIDIN | FUSIDIC ACID | 1 | Topical | 0 | CREAM | ||||||||||
| 123789243 | 12378924 | 39 | C | COCOIS | 2 | Topical | 0 | OINTMENT | |||||||||||
| 123789243 | 12378924 | 40 | C | POLYTAR | 2 | Unknown | 0 | UNSPECIFIED | |||||||||||
| 123789243 | 12378924 | 41 | C | CANESTEN | CLOTRIMAZOLE | 1 | Unknown | 0 | UNSPECIFIED | ||||||||||
| 123789243 | 12378924 | 42 | C | BUCLIZINE W/CODEINE/PARACETAMOL | 2 | Oral | 0 | TABLETS | |||||||||||
| 123789243 | 12378924 | 43 | C | DOXYCYCLINE. | DOXYCYCLINE | 1 | Oral | 2 ON DAY 1 THEN ONE EVERY DAY WITH EVENINQ MEALS | 0 | 100 | MG | CAPSULES | QD | ||||||
| 123789243 | 12378924 | 44 | C | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | ONE TABLET EVERY EVENING | 0 | 250 | MG | TABLETS | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123789243 | 12378924 | 1 | Psoriasis |
| 123789243 | 12378924 | 2 | Psoriasis |
| 123789243 | 12378924 | 3 | Blood glucose abnormal |
| 123789243 | 12378924 | 4 | Blood cholesterol increased |
| 123789243 | 12378924 | 15 | Pruritus |
| 123789243 | 12378924 | 16 | Pain |
| 123789243 | 12378924 | 17 | Gastrointestinal disorder therapy |
| 123789243 | 12378924 | 18 | Pain |
| 123789243 | 12378924 | 20 | Psoriasis |
| 123789243 | 12378924 | 32 | Diarrhoea |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123789243 | 12378924 | OT |
| 123789243 | 12378924 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123789243 | 12378924 | Inappropriate schedule of drug administration | |
| 123789243 | 12378924 | Lower respiratory tract infection | |
| 123789243 | 12378924 | Malaise | |
| 123789243 | 12378924 | Nephrolithiasis | |
| 123789243 | 12378924 | Psoriasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123789243 | 12378924 | 1 | 20131115 | 0 | ||
| 123789243 | 12378924 | 2 | 201203 | 0 |